Related Experiment Video

Updated: Jun 15, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

Correction: Gut microbiota affects PD-L1 therapy and its mechanism in melanoma

Shiqi Liu1, Jiahui Liu1, Yingwu Mei2

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.

Cancer Immunology, Immunotherapy : CII
|June 4, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
00:07

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

8.7K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Related Experiment Videos

Last Updated: Jun 15, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K
A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
00:07

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System

Published on: August 30, 2019

8.7K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

Articles linked to this work by shared authors, journal, and citation graph.

Longitudinal modeling of red blood cell distribution width dynamics and mortality risk in critically Ill patients with sepsis-associated acute kidney injury.

PloS one·2025

Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives.

Journal of translational medicine·2025

Decoding Rhizosphere Synergies: Pseudomonas and Bacillus Enhance Microbiome-Mediated Suppression of Rhizoctonia solani in Sugar Beet.

Phytopathology·2025

Quantitative evaluation of China's new health insurance payment policy based on the policy modeling consistency (PMC) index model.

BMC health services research·2025

Microglia/macrophage-specific deletion of TLR-4 protects against neural effects of diet-induced obesity in a sexually dimorphic manner.

Journal of neuroinflammation·2025

Increasing Aromaticity in Selenium-Embedded Hetero Ring Enables Stable Narrowband Multi-Resonance TADF Emitter for Long-Lifetime Pure-Green OLEDs.

Advanced materials (Deerfield Beach, Fla.)·2025

The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.

Cancer immunology, immunotherapy : CII·2026

Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer.

Cancer immunology, immunotherapy : CII·2026

Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.

Cancer immunology, immunotherapy : CII·2026

Mast cells in tumors: dual roles and therapeutic potential.

Cancer immunology, immunotherapy : CII·2026

Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma.

Cancer immunology, immunotherapy : CII·2026

HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression.

Cancer immunology, immunotherapy : CII·2026

Incidence of post-operative infections and antibiotic resistance trends: A clinical study.

Bioinformation·2026

From Symbiont to Potential Carcinogenic Contributor: Examining the Pathogenic Evolution of Morganella morganii in Colorectal Cancer.

Infection and drug resistance·2026

Spatially and temporally resolved assessment of quantitative skeletal muscle perfusion with non-contrast MRI in patients with PAD and healthy controls.

Quantitative imaging in medicine and surgery·2026

Pharmacist-coordinated IDST treatment bundle achievement and impact on mortality in MRSA bacteraemia: a single-centre retrospective cohort study.

Infection prevention in practice·2026

Four-year surveillance of major Gram-negative pathogens in a Saudi tertiary hospital: clinical distribution, comorbidity profiles, and antimicrobial resistance.

Expert review of anti-infective therapy·2026

"One Health"-based epidemiological investigation reveals the emergence of carbapenem-resistant Morganella spp. across diverse ecological niches.

Journal of global antimicrobial resistance·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us